Paediatric Formulation Development

Paediatric Formulation Development
Product Description

Glatt Pharmaceutical Services specializes in the development of pediatric formulations tailored to meet the specific needs of children. Recognizing that children require different dosage forms and strengths, Glatt focuses on creating age-appropriate, safe, and effective medications. Our expertise includes taste-masking technologies, patient-friendly dosage forms (e.g., micropellets, mini-tablets, and suspensions for reconstition or others), and ensuring precise dosing for pediatric patients. By leveraging advanced technologies and customized solutions, Glatt supports pharmaceutical companies in delivering high-quality pediatric medicines that enhance patient compliance and therapeutic outcomes.

Glatt Pharmaceutical Services GmbH & Co. K

  • DE
  • 2024
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Consultancy
Primary activities
Animal Health
Contract Manufacturer
Laboratory Services
OTC
Specifications
  • Details
    Paediatric Drug Product Development
  • Selling Points
    Quality Service
  • Model
    Service
  • Measured In
    Euro

Glatt Pharmaceutical Services GmbH & Co. K

  • DE
  • 2024
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Consultancy
Primary activities
Animal Health
Contract Manufacturer
Laboratory Services
OTC

More Products from Glatt Pharmaceutical Services GmbH & Co. K (3)

  • Formulation Development

    Product Formulation Development

    Formulation & process development of complex oral solids drug products. Specialized in solubility enhancement, drug delivery, controlled release, functional coating, granulation, pellets & micropellets. From technical feasibility to GMP for clinical trials and commercial manufacturing.Core compente...
  • New Inert starter beads CELLETS® 150 by ingredientpharm

    Product New Inert starter beads CELLETS® 150 by ingredientpharm

    We introduce CELLETS® 150, a new particle size for our pharmaceutical MCC spheres, ranging from 150-300 µm. State-of-the-art formulations with modified release profiles are often based on API carriers such as MCC pellets. CELLETS® are 100% MCC starter beads, offering unbeaten stability, sphericity, and sur...
  • Solubility enhancement of poorly soluble drugs

    Product Solubility enhancement of poorly soluble drugs

    Amorphous Solid Dispersions via fluidbed granulation to achieve free flowing and direct compressible granules of the API in an amorphous form. This solution offers an optimized downstream process in comparision to the standard spray drying process.

    Glatt Pharmaceutical Services supports the formulat...